Effects of Isolated Isoflavonoids on Lipids, Lipoproteins, Insulin Sensitivity, and Ghrelin in Postmenopausal Women

The low cardiovascular risk in Asian women has been thought to result from high isoflavonoid intake. In a double-blind, randomized, placebo-controlled trial, we studied the effects of isolated isoflavonoids (114 mg/d) on lipids, lipoproteins, insulin sensitivity, and ghrelin in 56 nondiabetic postme...

Full description

Saved in:
Bibliographic Details
Published in:The journal of clinical endocrinology and metabolism 2004-07, Vol.89 (7), p.3567-3572
Main Authors: Nikander, Eini, Tiitinen, Aila, Laitinen, Kalevi, Tikkanen, Matti, Ylikorkala, Olavi
Format: Article
Language:English
Subjects:
Adult
Aged
Biological and medical sciences
Cross-Over Studies
Double-Blind Method
Endocrinopathies
Female
Fundamental and applied biological sciences. Psychology
Ghrelin
Glucose Tolerance Test
Humans
Insulin Resistance
Isoflavones - pharmacology
Lipids - blood
Lipoproteins - blood
Lipoproteins, LDL - blood
Medical sciences
Middle Aged
Peptide Hormones - blood
Postmenopause - blood
Vertebrates: endocrinology
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The low cardiovascular risk in Asian women has been thought to result from high isoflavonoid intake. In a double-blind, randomized, placebo-controlled trial, we studied the effects of isolated isoflavonoids (114 mg/d) on lipids, lipoproteins, insulin sensitivity, and ghrelin in 56 nondiabetic postmenopausal women with a history of breast cancer. Isoflavonoid or placebo tablets were given for 3 months, and the treatment regimens crossed over after a 2-month washout period. The concentrations of total cholesterol, high- and low-density lipoprotein cholesterol, triglycerides, apolipoproteins B and A1, and lipoprotein (a) were not affected by isoflavonoids. However, during the isoflavonoid regimen, women with low-density lipoprotein cholesterol level above the median (4.20 mmol/liter) showed a rise [0.65 ± 0.60 (sd) mmol/liter], which was statistically different from the fall during the placebo regimen (−0.45 ± 0.67 mmol/liter, P = 0.009). Isoflavonoids did not affect insulin sensitivity as assessed by an oral 2-h glucose tolerance test (75 g). Changes in ghrelin levels differed (P = 0.048) during the isoflavonoid (−7.1 ± 151 μmol/liter) and placebo regimens (+47.9 ± 198 μmol/liter). In conclusion, we found no effects of isolated isoflavonoids on lipids, lipoproteins, or insulin sensitivity in postmenopausal women, implying no vascular benefit. Isoflavonoids may reduce ghrelin levels and thus hunger and weight.
ISSN:0021-972X
1945-7197
DOI:10.1210/jc.2003-032229